L474 (Ukoniq 200 mg)
Generic Name: umbralisib
Pill with imprint L474 is Green, Elliptical/Oval and has been identified as Ukoniq 200 mg. It is supplied by TG Therapeutics, Inc.
Ukoniq is used in the treatment of follicular lymphoma and belongs to the drug class multikinase inhibitors. Ukoniq 200 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for L474
Ukoniq
- Generic Name
- umbralisib
- Imprint
- L474
- Strength
- 200 mg
- Color
- Green
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- Multikinase inhibitors
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- TG Therapeutics, Inc.
- National Drug Code (NDC)
- 73150-0200
More about Ukoniq (umbralisib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy
- Drug images
- Pricing & coupons
- En español
- Drug class: multikinase inhibitors
- Latest FDA Alerts (1)
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.